Wednesday, August 15, 2012

Ampligen

Hemispherx Biopharma, manufacturer of Ampligen, has announced that the FDA has accepted its revised application as complete. A decision on marketing approval for Ampligen as a treatment for CFS is expected by Feb. 2, 2013, according to regulations that guide FDA. From RTT News: http://bit.ly/PZZHwg

No comments: